Androgen Metabolism and Reproductive Outcome
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Graz, Austria, 8036
- Medical University of Graz
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- pregnant women with and without PCOS
Exclusion Criteria:
- unable to consent
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Pregnant women with PCOS and offspring
Exposures of interest: Polycystic ovary Syndrome (PCOS) according to Rotterdam
|
|
Pregnant women without PCOS and offspring
Exposures of interest: Pregnant women without polycystic ovary Syndrome (PCOS) according to Rotterdam
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
correlation of testosterone between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
correlation of sexual hormon binding globulin between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of thyroid-stimulating hormone between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of androstendione between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of anti muellerian hormon between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of progesterone between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of dehydroepiandrosteron between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of Vitamin D levels between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of prolactin between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of insulin between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of human growth hormon between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of c-peptide between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of cortisol between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of luteinizing hormon between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of follicle stimulating hormone between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
correlation of estrogen levels between mother and offspring
Time Frame: day of birth (within average 24 hours)
|
day of birth (within average 24 hours)
|
|
maternal testosterone
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal sexual hormon binding globulin
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal thyroid-stimulating hormone
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal androstendione
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal anti muellerian hormon
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal progesterone
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal dehydroepiandrosteron
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal Vitamin D levels
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal prolactin
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal insulin
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal human growth hormon
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal c-peptide
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal cortisol
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal luteinizing hormon
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal follicle stimulating hormone
Time Frame: six weeks after birth
|
six weeks after birth
|
|
maternal estrogen levels
Time Frame: six weeks after birth
|
six weeks after birth
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update. 2005 Jul-Aug;11(4):357-74. doi: 10.1093/humupd/dmi013.
- Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007 Aug 25;370(9588):685-97. doi: 10.1016/S0140-6736(07)61345-2.
- Barry JA, Kay AR, Navaratnarajah R, Iqbal S, Bamfo JE, David AL, Hines M, Hardiman PJ. Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. J Obstet Gynaecol. 2010;30(5):444-6. doi: 10.3109/01443615.2010.485254.
- Anderson H, Fogel N, Grebe SK, Singh RJ, Taylor RL, Dunaif A. Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. J Clin Endocrinol Metab. 2010 May;95(5):2180-6. doi: 10.1210/jc.2009-2651. Epub 2010 Mar 12.
- van de Beek C, Thijssen JH, Cohen-Kettenis PT, van Goozen SH, Buitelaar JK. Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure? Horm Behav. 2004 Dec;46(5):663-9. doi: 10.1016/j.yhbeh.2004.06.010.
- Hickey M, Sloboda DM, Atkinson HC, Doherty DA, Franks S, Norman RJ, Newnham JP, Hart R. The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab. 2009 Oct;94(10):3714-20. doi: 10.1210/jc.2009-0544. Epub 2009 Jun 30.
- Goodarzi MO, Guo X, Yildiz BO, Stanczyk FZ, Azziz R. Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters. Am J Obstet Gynecol. 2007 Apr;196(4):398.e1-5; discussion 398.e5-6. doi: 10.1016/j.ajog.2006.12.009.
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.